Cerus Corporation to Release Fourth Quarter and Full Year 2020 Financial Results on February 25, 2021Business Wire • 02/11/21
Cerus Corporation Announces Preliminary Fourth Quarter and Full Year 2020 Product RevenueBusiness Wire • 01/11/21
Cerus' Distribution Partner, CEI, Announces Three-Year Tender Award with the Minas Gerais Hematology and Hemotherapy Center Foundation (HemoMinas) in Brazil for the INTERCEPT Blood System for PlateletsBusiness Wire • 12/15/20
Cerus Corporation Announces Presentation of Study Results with INTERCEPT-treated COVID-19 Convalescent Plasma at the American Society of Hematology Annual MeetingBusiness Wire • 12/05/20
Cerus Corporation Announces FDA Approval for INTERCEPT Blood System for CryoprecipitationBusiness Wire • 11/30/20
Cerus Corporation (CERS) CEO Obi Greenman on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha • 10/30/20
Cerus (CERS) May Report Negative Earnings: Know the Trend Ahead of Next Week's ReleaseZacks Investment Research • 10/22/20
Cerus Corporation to Release Third Quarter 2020 Financial Results on October 29, 2020Business Wire • 10/19/20
Cerus Corporation Announces Five-Year FDA Contract for the Development of Next Generation Pathogen Reduction Technology to Treat Whole BloodBusiness Wire • 10/13/20
Cerus Corporation Announces Schedule of Presentations at the AABB 2020 Virtual Annual MeetingBusiness Wire • 09/28/20
Cerus INTERCEPT Blood System Kit Shipments Surpass 7.5 Million Treatable Platelet and Plasma Doses Since LaunchBusiness Wire • 08/07/20
Cerus Corporation (CERS) CEO Obi Greenman on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha • 08/05/20
Cerus Corporation Announces a Five-Year Tender Award by the Hong Kong Red Cross Blood Transfusion Service for INTERCEPT Blood SystemsBusiness Wire • 07/30/20
Cerus Corporation to Release Second Quarter 2020 Financial Results on August 4, 2020Business Wire • 07/23/20
Cerus Corporation Reports Successful Inactivation of SARS-CoV-2 with the INTERCEPT Blood System for PlasmaBusiness Wire • 07/07/20